Article Text
Novel treatment (new drug/intervention; established drug/procedure in new situation)
CASE REPORT
Living donor renal transplant in a patient with end-stage renal disease due to Hermansky-Pudlak syndrome
Summary
Hermansky-Pudlak syndrome (HPS) is a rare genetic disorder characterised by oculocutaneous albinism, bleeding diathesis and end-stage renal disease (ESRD), due to interstitial deposition of ceroid lipofuscin. Renal transplantation is potentially a definitive treatment option for patients with ESRD due to HPS. Herein, we describe the case of a 55-year-old male patient with HPS that successfully underwent a living donor kidney transplant. We also emphasise the importance of multidisciplinary input during the preoperative, perioperative and postoperative phases in this high-risk clinical scenario.
- renal transplantation
- transplantation
- haematology (incl blood transfusion)
- urological surgery